Peter Amaya is currently the Associate Director at AstraZeneca, focusing on cell line development and upstream bioprocessing of large molecule biopharmaceuticals. Previously, they held the position of Senior Scientist at AstraZeneca from 2017 to 2022, where they executed upstream process development and managed cross-functional teams. Prior to that, Peter served as a Scientist at MedImmune from 2017 to 2019, and as a Graduate Research Assistant at The Ohio State University from 2012 to 2017, where they designed innovative bioreactor systems and optimized cell separation processes.
This person is not in the org chart
This person is not in any teams
This person is not in any offices